- Home
- NVVE vs VTAK Comparison
NVVE vs VTAK Comparison
Compare NVVE & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVVE
- VTAK
- Stock Information
- Founded
- NVVE 1996
- VTAK 2002
- Country
- NVVE United States
- VTAK United States
- Employees
- NVVE N/A
- VTAK N/A
- Industry
- NVVE Oil Refining/Marketing
- VTAK Medical/Dental Instruments
- Sector
- NVVE Energy
- VTAK Health Care
- Exchange
- NVVE Nasdaq
- VTAK Nasdaq
- Market Cap
- NVVE 4.2M
- VTAK 4.1M
- IPO Year
- NVVE N/A
- VTAK 2018
- Fundamental
- Price
- NVVE $0.19
- VTAK $2.28
- Analyst Decision
- NVVE
- VTAK
- Analyst Count
- NVVE 0
- VTAK 0
- Target Price
- NVVE N/A
- VTAK N/A
- AVG Volume (30 Days)
- NVVE 20.6M
- VTAK 80.8K
- Earning Date
- NVVE 11-13-2025
- VTAK 11-14-2025
- Dividend Yield
- NVVE N/A
- VTAK N/A
- EPS Growth
- NVVE N/A
- VTAK N/A
- EPS
- NVVE N/A
- VTAK N/A
- Revenue
- NVVE $4,949,747.00
- VTAK $600,000.00
- Revenue This Year
- NVVE $892.33
- VTAK $822.86
- Revenue Next Year
- NVVE N/A
- VTAK $168.42
- P/E Ratio
- NVVE N/A
- VTAK N/A
- Revenue Growth
- NVVE N/A
- VTAK 37.62
- 52 Week Low
- NVVE $0.18
- VTAK $2.20
- 52 Week High
- NVVE $5.02
- VTAK $15.68
- Technical
- Relative Strength Index (RSI)
- NVVE 34.19
- VTAK 38.47
- Support Level
- NVVE $0.20
- VTAK $2.22
- Resistance Level
- NVVE $0.25
- VTAK $2.56
- Average True Range (ATR)
- NVVE 0.03
- VTAK 0.15
- MACD
- NVVE 0.00
- VTAK -0.05
- Stochastic Oscillator
- NVVE 0.93
- VTAK 9.41
About NVVE Nuvve Holding Corp.
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.
About VTAK Catheter Precision Inc.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.